These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9748054)

  • 41. Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers.
    Dixon RM; Meire HB; Evans DH; Watt H; On N; Posner J; Rolan PE
    Cephalalgia; 1997 Oct; 17(6):639-46. PubMed ID: 9350383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of human motor cortex excitability by single doses of amantadine.
    Reis J; John D; Heimeroth A; Mueller HH; Oertel WH; Arndt T; Rosenow F
    Neuropsychopharmacology; 2006 Dec; 31(12):2758-66. PubMed ID: 16794570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Safety profile of 311C90 (zolmitriptan)].
    Morales Asín F
    Neurologia; 1998 Oct; 13 Suppl 2():25-30. PubMed ID: 9859692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical applications of zolmitriptan (Zomig, 311C90).
    Lipton RB; Stewart WF
    Cephalalgia; 1997 Oct; 17 Suppl 18():53-9. PubMed ID: 9399017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the pharmacokinetics and tolerability of the novel antimigraine compound zolmitriptan in adolescents and adults.
    Dixon R; Engleman K; Kemp J; Ruckle JL
    J Child Adolesc Psychopharmacol; 1999; 9(1):35-42. PubMed ID: 10357516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution of zolmitriptan into the CNS in healthy volunteers: a positron emission tomography study.
    Wall A; Kågedal M; Bergström M; Jacobsson E; Nilsson D; Antoni G; Frändberg P; Gustavsson SA; Långström B; Yates R
    Drugs R D; 2005; 6(3):139-47. PubMed ID: 15869317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.
    Ziemann U; Lönnecker S; Steinhoff BJ; Paulus W
    Ann Neurol; 1996 Sep; 40(3):367-78. PubMed ID: 8797526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of phenytoin on cortical excitability in humans.
    Chen R; Samii A; Caños M; Wassermann EM; Hallett M
    Neurology; 1997 Sep; 49(3):881-3. PubMed ID: 9305361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcranial magnetic stimulation reduces masseter motoneuron pool excitability throughout the cortical silent period.
    Sowman PF; Flavel SC; McShane CL; Miles TS; Nordstrom MA
    Clin Neurophysiol; 2008 May; 119(5):1119-29. PubMed ID: 18313355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is motor cortex excitability associated with personality factors? A replication study.
    Schecklmann M; Landgrebe M; Frank E; Sand PG; Eichhammer P; Hajak G; Langguth B
    Int J Psychophysiol; 2012 Mar; 83(3):323-7. PubMed ID: 22154848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmaco-transcranial magnetic stimulation studies of motor excitability.
    Ziemann U
    Handb Clin Neurol; 2013; 116():387-97. PubMed ID: 24112911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral zolmitriptan is effective in the acute treatment of cluster headache.
    Bahra A; Gawel MJ; Hardebo JE; Millson D; Breen SA; Goadsby PJ
    Neurology; 2000 May; 54(9):1832-9. PubMed ID: 10802793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modification of motor cortical excitability by an acetylcholinesterase inhibitor.
    Korchounov A; Ilic TV; Schwinge T; Ziemann U
    Exp Brain Res; 2005 Jul; 164(3):399-405. PubMed ID: 15991031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcranial magnetic stimulation: applications for neuropsychopharmacology.
    Kähkönen S; Ilmoniemi RJ
    J Psychopharmacol; 2004 Jun; 18(2):257-61. PubMed ID: 15260916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cortical excitability in tramadol dependent patients: A transcranial magnetic stimulation study.
    Khedr EM; Gabra RH; Noaman M; Abo Elfetoh N; Farghaly HSM
    Drug Alcohol Depend; 2016 Dec; 169():110-116. PubMed ID: 27810653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of human motor cortex by ethanol. A transcranial magnetic stimulation study.
    Ziemann U; Lönnecker S; Paulus W
    Brain; 1995 Dec; 118 ( Pt 6)():1437-46. PubMed ID: 8595475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists.
    Ferrari MD
    Neurology; 1997 Mar; 48(3 Suppl 3):S21-4. PubMed ID: 9071266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
    Limmroth V; Kazarawa Z; Fritsche G; Diener HC
    Lancet; 1999 Jan; 353(9150):378. PubMed ID: 9950449
    [No Abstract]   [Full Text] [Related]  

  • 59. Zolmitriptan receives migraine indication.
    Am J Health Syst Pharm; 1998 Jan; 55(2):110, 113. PubMed ID: 9465973
    [No Abstract]   [Full Text] [Related]  

  • 60. Is a central action of acute antimigraine drugs essential?
    Goadsby PJ
    Cephalalgia; 1997 Jun; 17 Suppl 17():10-1. PubMed ID: 9218879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.